| Ticker Details |
|
Cogent Biosciences, Inc.
|
| IPO Date: |
March 26, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.61B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.31 | 3.14%
|
| Avg Daily Range (30 D): |
$0.79 | 2.13%
|
| Avg Daily Range (90 D): |
$0.77 | 2.46%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.7M |
| Avg Daily Volume (30 D): |
1.82M |
| Avg Daily Volume (90 D): |
2.48M |
| Trade Size |
| Avg Trade Size (Sh.): |
103 |
| Avg Trade Size (Sh.) (30 D): |
71 |
| Avg Trade Size (Sh.) (90 D): |
82 |
| Institutional Trades |
| Total Institutional Trades: |
2,487 |
| Avg Institutional Trade: |
$1.99M |
| Avg Institutional Trade (30 D): |
$3.24M |
| Avg Institutional Trade (90 D): |
$2.8M |
| Avg Institutional Trade Volume: |
.15M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.71M |
| Avg Closing Trade (30 D): |
$8.82M |
| Avg Closing Trade (90 D): |
$10.24M |
| Avg Closing Volume: |
206.42K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-2.05
|
$-.5
|
$-.53
|
|
Diluted EPS
|
$-2.05
|
$-.5
|
$-.53
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-294.37M
|
$-80.93M
|
$-73.53M
|
|
Operating Income / Loss
|
$-307.6M
|
$-83.36M
|
$-75.58M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$28.59M
|
$-1.97M
|
$1.6M
|
|
PE Ratio
|
|
|
|
|
|
|